Crohn's Disease Clinical Trials in Los Angeles

Showing 21-40 of 65 trials

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00102921

The purpose of this research study is to investigate the effects of an investigational medication, called CCX282-B, on safety and on the some of the symptoms of Crohn's Disease in patients who are experiencing an active flare-up of moderate to severe Crohn's Disease.

Crohn Disease

Amgen70 participantsStarted Aug 2004

Los Angeles, California, United States • Golden, Colorado, United States • Littleton, Colorado, United States +11 more locations

TERMINATEDPhase 1< 1 mile

Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease

NCT05130983

Protocol Summary * Title: A Phase I study of ExoFlo, an ex vivo culture-expanded adult allogeneic bone marrow mesenchymal stem cell derived extracellular vesicle isolate product, for the treatment of medically refractory Crohn's disease. * Short Title: ExoFlo for Crohn's Disease * Phase: 1 * Methodology: Open label * Study Duration: 24 months * Subject Participation: 58 weeks * Single or Multi-Site: Multi-Site

Crohn DiseaseInflammatory Bowel Diseases

Direct Biologics, LLC3 participantsStarted Jan 2023

Los Angeles, California, United States • New York, New York, United States

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease

Crohn's Disease Trials in Other Cities

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Reactive vs. Proactive Pain Control in IBD

Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease

Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Entyvio (Vedolizumab) Long Term Safety Study

Ganglioside and IBD

A Study To Monitor Long-Term Treatment With PF-00547659

Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

Other Conditions in Los Angeles